Related Experiment Video

Updated: May 21, 2026

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer
06:01

A Genetically Engineered Mouse Model of Sporadic Colorectal Cancer

Published on: July 6, 2017

Colorectal cancer and RASSF family--a special emphasis on RASSF1A

Maria Sofia Fernandes1, Fátima Carneiro, Carla Oliveira

  • 1Institute of Molecular Pathology and Immunology of the University of Porto, Porto, Portugal.

International Journal of Cancer
|June 27, 2012
PubMed

Insights

RAS-association domain family (RASSF) proteins are tumor suppressors silenced by methylation in colorectal cancer (CRC). RASSF inactivation in CRC offers potential for new targeted therapies and biomarkers.

Area of Science:

  • Molecular Biology
  • Oncology
  • Genetics

Background:

  • The RAS-association domain family (RASSF) comprises 10 proteins involved in cell cycle regulation, apoptosis, and microtubule stability.
  • RASSF proteins are recognized for their role as tumor suppressors, with implications in tumorigenesis.
  • Unlike KRAS, RASSFs are frequently silenced via aberrant promoter methylation in colorectal cancer (CRC).

Purpose of the Study:

  • To review the current understanding of RASSF inactivation mechanisms in CRC.
  • To highlight the specific role of RASSF1A, RASSF2, and RASSF5 methylation in CRC development.
  • To explore the potential of RASSFs as biomarkers and therapeutic targets for CRC.

Main Methods:

  • Literature review of studies on RASSF gene family.
  • Analysis of RASSF methylation patterns in colorectal cancer tissues.
  • Investigation of RASSF biological functions and their link to cancer.

Main Results:

  • Aberrant promoter methylation is a key mechanism for RASSF silencing in CRC.
  • RASSF1A, RASSF2, and RASSF5 are particularly implicated in CRC pathogenesis.
  • The precise mechanisms by which RASSF inactivation contributes to CRC remain under investigation.

Conclusions:

  • RASSF inactivation through methylation is a significant event in colorectal cancer.
  • RASSFs represent promising biomarkers for CRC detection and prognosis.
  • Targeting RASSF pathways may offer novel therapeutic strategies for CRC treatment.

More Related Videos

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells06:44

Bioluminescence Resonance Energy Transfer (BRET)-Based Assay for Measuring Interactions of CRAF with 14-3-3 Proteins in Live Cells

Published on: March 1, 2024

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans08:12

Identification of EGFR and RAS Inhibitors using Caenorhabditis elegans

Published on: October 5, 2020

Related Concept Videos

The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: